LAG3 antibody (Internal Region)
Quick Overview for LAG3 antibody (Internal Region) (ABIN7218480)
Target
See all LAG3 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- Internal Region
-
Purpose
- CD223 Polyclonal Antibody
-
Specificity
- CD223 Polyclonal Antibody detects endogenous levels of CD223 protein.
-
Purification
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen
-
Immunogen
- Synthesized peptide derived from the Internal region of human CD223
-
Isotype
- IgG
-
-
-
-
Application Notes
- Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB (1:500-1:2000), ELISA (1:20000). Not yet tested in other applications.
-
Comment
-
Primary Antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- PBS containing 50 % Glycerol, 0.5 % BSA and 0.02 % Sodium Azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.
-
-
- LAG3 (Lymphocyte-Activation Gene 3 (LAG3))
-
Alternative Name
- CD223
-
Background
- Rabbit Anti-CD223 Polyclonal Antibody,LAG3, FDC, Lymphocyte activation gene 3 protein, LAG-3, Protein FDC, CD223,Lymphocyte-activation protein 3 belongs to Ig superfamily and contains 4 extracellular Ig-like domains. The LAG3 gene contains 8 exons. The sequence data, exon/intron organization, and chromosomal localization all indicate a close relationship of LAG3 to CD4.,Lymphocyte activation gene 3 protein
-
Molecular Weight
- observerd band 57kDa
-
Gene ID
- 3902
-
UniProt
- P18627
-
Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints
Target
-